Panntherapi Advances Epilepsy Treatment with PTI5803 Clinical Trial
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…
Academic health systems can achieve high-performing clinical trials programs by implementing six strategic actions, driving…
The latest Stark Integrity podcast discusses UPICs, clinical trials, and compliance, as well as the…
A Park Ridge woman with movement issues has made a remarkable recovery after participating in…
A groundbreaking clinical trial is underway to assess a revolutionary blood test that could detect…
A recent study has revealed the potential of combining BXCL701 with pembrolizumab in treating metastatic…
A new clinical trial reveals that less aggressive treatment for low-risk breast cancer is just…